OSU Brain & Spine Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer3 trials
• Childhood cancers1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Dizal Pharmaceuticals1 trial
• Gilead Sciences1 trial
• Nuvalent Inc.1 trial

Running trials

• Active, not recruiting

  A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)

  NCT05668988· Phase 3· Dizal Pharmaceuticals· Source

• Recruiting

  A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

  NCT05384626· Phase 1/2· Nuvalent Inc.· Source

  Contact: Logan Roof, MD, MSCR (principal investigator)

• Active, not recruiting

  Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)

  NCT05186974· Phase 2· Gilead Sciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Lung cancer1 recruiting